Nightstar Therapeutics plc (NASDAQ: NITE) is a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases including choroideremia, X-linked retinitis pigmentosa and Best vitelliform macular dystrophy.
Company Information
- Industry
- Biotechnology
- Company Type
- Public Company
- Founded
- 2013
- Employee Range
- 11-50
- Revenue Range
- $5,000,000 - $10,000,000
Location
- Address
- City
- London
- Region
- england
- Postal Code
- Country
Specialties
Gene TherapyOphthalmologyRetinal DiseasesBiotechnologyChoroideremiaRetinitis PigmentosaBest Vitelliform Macular DystrophyStargardt Disease
